260 related articles for article (PubMed ID: 29487285)
21. Poly(ADP-ribosyl)ation enhancement in brain cell nuclei is associated with diabetic neuropathy.
Kuchmerovska T; Shymanskyy I; Donchenko G; Kuchmerovskyy M; Pakirbaieva L; Klimenko A
J Diabetes Complications; 2004; 18(4):198-204. PubMed ID: 15207836
[TBL] [Abstract][Full Text] [Related]
22. Insights into PARP Inhibitors' Selectivity Using Fluorescence Polarization and Surface Plasmon Resonance Binding Assays.
Papeo G; Avanzi N; Bettoni S; Leone A; Paolucci M; Perego R; Quartieri F; Riccardi-Sirtori F; Thieffine S; Montagnoli A; Lupi R
J Biomol Screen; 2014 Sep; 19(8):1212-9. PubMed ID: 24916412
[TBL] [Abstract][Full Text] [Related]
23. The inhibition of poly(ADP-ribose) polymerase enhances growth rates of ataxia telangiectasia cells.
Marecki JC; McCord JM
Arch Biochem Biophys; 2002 Jun; 402(2):227-34. PubMed ID: 12051667
[TBL] [Abstract][Full Text] [Related]
24. Use of Inosine Monophosphate Dehydrogenase Activity Assay to Determine the Specificity of PARP-1 Inhibitors.
Anthony S; Peterson JR; Ji Y
Methods Mol Biol; 2017; 1608():337-342. PubMed ID: 28695520
[TBL] [Abstract][Full Text] [Related]
25. Poly (ADP-ribose) polymerase (PARP) is essential for sulfur mustard-induced DNA damage repair, but has no role in DNA ligase activation.
Bhat KR; Benton BJ; Ray R
J Appl Toxicol; 2006; 26(5):452-7. PubMed ID: 16906506
[TBL] [Abstract][Full Text] [Related]
26. Molecular Mechanisms of PARP-1 Inhibitor 7-Methylguanine.
Nilov D; Maluchenko N; Kurgina T; Pushkarev S; Lys A; Kutuzov M; Gerasimova N; Feofanov A; Švedas V; Lavrik O; Studitsky VM
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245127
[TBL] [Abstract][Full Text] [Related]
27. A scintillation proximity assay for poly(ADP-ribose) polymerase.
Cheung A; Zhang J
Anal Biochem; 2000 Jun; 282(1):24-8. PubMed ID: 10860495
[TBL] [Abstract][Full Text] [Related]
28. S-nitrosation on zinc finger motif of PARP-1 as a mechanism of DNA repair inhibition by arsenite.
Zhou X; Cooper KL; Huestis J; Xu H; Burchiel SW; Hudson LG; Liu KJ
Oncotarget; 2016 Dec; 7(49):80482-80492. PubMed ID: 27741521
[TBL] [Abstract][Full Text] [Related]
29. The role of poly(ADP-ribose) polymerase-1 in CNS disease.
Kauppinen TM; Swanson RA
Neuroscience; 2007 Apr; 145(4):1267-72. PubMed ID: 17084037
[TBL] [Abstract][Full Text] [Related]
30. Allosteric regulation of DNA binding and target residence time drive the cytotoxicity of phthalazinone-based PARP-1 inhibitors.
Arnold MR; Langelier MF; Gartrell J; Kirby IT; Sanderson DJ; Bejan DS; Šileikytė J; Sundalam SK; Nagarajan S; Marimuthu P; Duell AK; Shelat AA; Pascal JM; Cohen MS
Cell Chem Biol; 2022 Dec; 29(12):1694-1708.e10. PubMed ID: 36493759
[TBL] [Abstract][Full Text] [Related]
31. A Poly-ADP-Ribose Trigger Releases the Auto-Inhibition of a Chromatin Remodeling Oncogene.
Singh HR; Nardozza AP; Möller IR; Knobloch G; Kistemaker HAV; Hassler M; Harrer N; Blessing C; Eustermann S; Kotthoff C; Huet S; Mueller-Planitz F; Filippov DV; Timinszky G; Rand KD; Ladurner AG
Mol Cell; 2017 Dec; 68(5):860-871.e7. PubMed ID: 29220653
[TBL] [Abstract][Full Text] [Related]
32. Effect of parthanatos on ropivacaine-induced damage in SH-SY5Y cells.
Zheng T; Zheng CY; Zheng XC; Zhao RG; Chen YQ
Clin Exp Pharmacol Physiol; 2017 May; 44(5):586-594. PubMed ID: 28079261
[TBL] [Abstract][Full Text] [Related]
33. Chain length analysis of ADP-ribose polymers generated by poly(ADP-ribose) polymerase (PARP) as a function of beta-NAD+ and enzyme concentrations.
Mendoza-Alvarez H; Chavez-Bueno S; Alvarez-Gonzalez R
IUBMB Life; 2000 Aug; 50(2):145-9. PubMed ID: 11185961
[TBL] [Abstract][Full Text] [Related]
34. Impaired PARP activity in response to the β-adrenergic receptor agonist isoproterenol.
Thomas M; Palombo P; Schuhmacher T; von Scheven G; Bazylianska V; Salzwedel J; Schäfer N; Bürkle A; Moreno-Villanueva M
Toxicol In Vitro; 2018 Aug; 50():29-39. PubMed ID: 29438734
[TBL] [Abstract][Full Text] [Related]
35. Comparative inhibitory profile and distribution of bacterial PARPs, using Clostridioides difficile CD160 PARP as a model.
García-Saura AG; Zapata-Pérez R; Hidalgo JF; Sánchez-Ferrer Á
Sci Rep; 2018 May; 8(1):8056. PubMed ID: 29795234
[TBL] [Abstract][Full Text] [Related]
36. Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death.
Ying W; Sevigny MB; Chen Y; Swanson RA
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12227-32. PubMed ID: 11593040
[TBL] [Abstract][Full Text] [Related]
37. Delocalization of nucleolar poly(ADP-ribose) polymerase-1 to the nucleoplasm and its novel link to cellular sensitivity to DNA damage.
Rancourt A; Satoh MS
DNA Repair (Amst); 2009 Mar; 8(3):286-97. PubMed ID: 19144573
[TBL] [Abstract][Full Text] [Related]
38. Altered poly(ADP-ribose) metabolism impairs cellular responses to genotoxic stress in a hypomorphic mutant of poly(ADP-ribose) glycohydrolase.
Gao H; Coyle DL; Meyer-Ficca ML; Meyer RG; Jacobson EL; Wang ZQ; Jacobson MK
Exp Cell Res; 2007 Mar; 313(5):984-96. PubMed ID: 17276427
[TBL] [Abstract][Full Text] [Related]
39. Crystal structure of the catalytic domain of human PARP2 in complex with PARP inhibitor ABT-888.
Karlberg T; Hammarström M; Schütz P; Svensson L; Schüler H
Biochemistry; 2010 Feb; 49(6):1056-8. PubMed ID: 20092359
[TBL] [Abstract][Full Text] [Related]
40. Role of poly(ADP-ribose) polymerase in rapid intracellular acidification induced by alkylating DNA damage.
Affar el B; Shah RG; Dallaire AK; Castonguay V; Shah GM
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):245-50. PubMed ID: 11756665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
